Clinical Trial Update: L-Arginine in the Treatment of Peripheral Arterial Disease [NA]

View source ↗

Summary

Stanford University's clinical trial evaluated L-Arginine as a treatment for Peripheral Artery Disease and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Stanford University | Conditions: Cardiovascular Diseases, Peripheral Vascular Diseases | NA | Status: COMPLETED